wrt ADMP's EpiPen CRL + resubmittal, it does look like it may be approved earlier than ATRS. I don't know what that means in terms of ADMP PPS or conversely, ATRS future market shares for Epi.
Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA